↓ Skip to main content

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study

Overview of attention for article published in Frontiers in oncology, March 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
Published in
Frontiers in oncology, March 2020
DOI 10.3389/fonc.2020.00271
Pubmed ID
Authors

Yi Li, Chengcheng Gong, Qianyi Lu, Zhaochun Zhou, Ting Luo, Wei Li, Gang Li, Rui Ge, Fei Xu, Biyun Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 17%
Other 6 15%
Lecturer 4 10%
Student > Ph. D. Student 4 10%
Student > Doctoral Student 2 5%
Other 8 20%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 12 29%
Pharmacology, Toxicology and Pharmaceutical Science 9 22%
Economics, Econometrics and Finance 4 10%
Nursing and Health Professions 2 5%
Immunology and Microbiology 2 5%
Other 1 2%
Unknown 11 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2020.
All research outputs
#17,284,203
of 26,163,973 outputs
Outputs from Frontiers in oncology
#6,849
of 22,911 outputs
Outputs of similar age
#235,893
of 387,962 outputs
Outputs of similar age from Frontiers in oncology
#160
of 486 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,911 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 387,962 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 486 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.